OWENS DAVID (Chief Medical Officer) purchased 1.8% of their position (2.50K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $10.4K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/20/2022ACC: 0001829126-22-017005
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+2.50K
Net shares
Net buyer
$10.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
$4.15
Trade value
$10.38K
% of position
1.8%
9/16/2022
138.67K→141.17K
Total
Net shares
+2.50K
Net value
$10.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2022 | P · Purchase | +2.50K | $4.15 | $10.38K | 1.8% | 138.67K | 141.17K |
| Total | +2.50K | $10.38K | ||||||
Derivative Transactions0
No derivative transactions reported